Table 1.
Group | Animal | Immunogen | Group | Animal | Immunogen |
---|---|---|---|---|---|
1 | 27 | HI Env phage (1.0μg/dose) | 6 | 55 | YU2gp140 (1.5μg/dose) |
28 | 56 | ||||
29 | 57 | ||||
30 | 58 | ||||
2 | 35 | LO Env Phage (est.100ng/dose) | 7 | 59 | YU2gp140:gpD (1.5μg/dose) |
36 | 60 | ||||
37 | 61 | ||||
38 | 62 | ||||
3 | 43 | WT Phage | 8 | 63 | Prime HI Env phage/boost YU2gp140a |
44 | 64 | ||||
45 | 65 | ||||
46 | 66 | ||||
4 | 47 | YU2gp140 (20μg/dose) | 9 | 67 | Prime YU2gp140/boost HI Env phagea |
48 | 68 | ||||
49 | 69 | ||||
50 | 70 | ||||
5 | 51 | YU2gp140:gpD (20μg/dose) | |||
52 | |||||
53 | |||||
54 |
For prime/boost groups, immunizations were at 0 weeks and boosting immunizations were at 5,10, 15 weekds′